Department of Cardiology and Electrotherapy, Medical University of Gdansk, 80-952 Gdansk, Poland.
Department of Nonivasive Cardiac Diagnostics, Medical University of Gdansk, 80-952 Gdansk, Poland.
Int J Environ Res Public Health. 2021 Nov 5;18(21):11631. doi: 10.3390/ijerph182111631.
Patients with cardiac amyloidosis (CA) have an increased risk of sudden cardiac death. (SCD). However, the role of an implantable cardioverter-defibrillator in the primary prevention of SCD in this group of patients is still controversial. We present a case with CA with recurrent syncope and non-sustained ventricular tachycardia. In order to further stratify the risk of SCD, an electrophysiological study with endocardial electroanatomic voltage mapping was performed prior to the ICD placement.
患有心脏淀粉样变性(CA)的患者发生心源性猝死(SCD)的风险增加。然而,在这组患者中,植入式心脏复律除颤器(ICD)在预防 SCD 中的作用仍存在争议。我们报告了 1 例 CA 伴反复晕厥和非持续性室性心动过速患者。为了进一步分层 SCD 风险,在植入 ICD 之前进行了心内膜电生理研究和心内膜电解剖电压标测。